Previous 10 | Next 10 |
2024-04-10 05:15:02 ET KeyBanc analyst issues OVERWEIGHT recommendation for CERT on April 10, 2024 01:31AM ET. CERT was trading at $18.51 at issue of the analyst recommendation. The overall analyst consensus : STRONG BUY. Current analyst recommendations are : recommendat...
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market close on Tuesday, May 7 th , 2024. Company management will host a conferenc...
2024-03-28 04:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-14 11:17:45 ET More on Definitive Healthcare: Definitive Healthcare Corp. 2023 Q4 - Results - Earnings Call Presentation Definitive Healthcare Corp. (DH) Q4 2023 Earnings Call Transcript Definitive Healthcare reports Q4 results Definitive Healthcare's...
2024-03-08 07:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Proposed Transaction with Amarillo Mineração do Brasil Ltda. to strengthen balance sheet and address lack of liquidity in the junior mining sector Company well-positioned to drive future growth via its operating Minera Don Nicolas gold mine in Argentina and its Mont Sorcier develop...
Metallurgical test work confirms DRI grade iron concentrate with combined Silica and Alumina below 2.5% (All numbers reported in US dollars) TORONTO, ON / ACCESSWIRE / March 1, 2024 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF) ("Cerrado" or the "Company") is pleased to announce positive ...
PRINCETON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter of fiscal year 2023. Fourth Quarter Highlights: Revenue was $88.0 million, compared to $86.6 million i...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
2024-02-05 14:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting January 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling ...
News, Short Squeeze, Breakout and More Instantly...
Q2 Production of 16,255 Gold Equivalent Ounces ("GEO") vs 11,204 GEO in Q1, 2024. High-Grade ore from Calandrias Norte and continued ramp-up at Heap leach operations are supporting strong quarterly production. MDN 43-101 Preliminary Economic Assessment and Updated Mineral Resource E...
2024-07-16 14:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed...